Workflow
新零售业务
icon
Search documents
大连友谊:2025年前三季度收入同比增长107.52%
Zheng Quan Ri Bao Wang· 2025-12-09 14:12
证券日报网讯12月9日,大连友谊(000679)在互动平台回答投资者提问时表示,公司2025年前三季度 收入同比增长107.52%,主要为公司2025年下半年启动的新零售业务带来的收入贡献。增幅较大的原因 主要为去年同期该业务尚处于起步阶段。 ...
顶层会议再强调内需主导,后续仍是政策突破方向
Xuan Gu Bao· 2025-12-08 23:17
据新华社报道,中共中央政治局12月8日召开会议,分析研究2026年经济工作。会议提出,要坚持内需 主导,建设强大国内市场;坚持创新驱动,加紧培育壮大新动能。 国信证券,本次会议提出"持续扩大内需、优化供给、做优增量、盘活存量"以及"坚持内需主导,建设 强大国内市场"。很明显地,本次会议不再像过去两年那样分别提及"消费"和"投资"且把"大力提振消 费"放在首位,而是统合成"内需",背后或是考虑给地方政府提供更大的自由度,让其可以因地制宜实 施"扩消费"或"促投资"政策,而非集中精力扩消费却忽略了有效投资的重要性。 申万宏源指出,政策仍将内需置于核心,明确提出"要坚持内需主导","十五五"主要目标中提出"居民 消费率明显提高",2024年居民商品消费已基本恢复,但人均服务消费较疫情前趋势值存1923元缺口, 或成政策突破方向。 惠发食品:公司 升级"中央厨房+智慧餐饮" 模式, 推动智慧餐饮建设。另外,公司与沙县小吃集团有 合作。 *免责声明:文章内容仅供参考,不构成投资建议 *风险提示:股市有风险,入市需谨慎 公司方面,据上市公司互动平台表示, 丽尚国潮:公司布局新消费及新零售领域, 通过线上线下融合模式发展零 ...
研报掘金丨东海证券:维持益丰药房“买入”评级,多元化业务打开长期增长空间
Ge Long Hui A P P· 2025-11-12 07:45
Core Viewpoint - Donghai Securities report indicates that Yifeng Pharmacy achieved a net profit attributable to shareholders of 1.225 billion yuan in the first three quarters of 2025, representing a year-on-year increase of 10.27% [1] Financial Performance - In Q3 alone, the company reported a net profit attributable to shareholders of 345 million yuan, which is a year-on-year increase of 10.14% but a quarter-on-quarter decrease of 19.98% [1] Operational Efficiency - The company has demonstrated robust profit growth through cost reduction, efficiency enhancement, and optimization of its operational structure, showcasing its excellent management capabilities and operational resilience [1] Business Strategy - The new retail business continues to grow significantly, and the initial results of the non-pharmaceutical innovation strategy are becoming evident [1] - The company plans to launch a transformation of non-pharmaceutical innovative stores in 2025, with nationwide promotion expected in 2026, which is anticipated to open new growth opportunities [1] Market Position - Yifeng Pharmacy is recognized as a leading retail pharmacy with stable operations and unique refined management capabilities, while its diversified business approach is expected to provide long-term development potential [1] Investment Rating - The report maintains a "Buy" rating for the company [1]
丽尚国潮(600738) - 丽尚国潮2025年前三季度主要经营数据公告
2025-10-30 12:36
证券代码:600738 证券简称:丽尚国潮 公告编号:2025-066 兰州丽尚国潮实业集团股份有限公司 2025 年前三季度主要经营数据公告 一、2025 年第三季度,公司零售百货门店无关闭情况。 二、2025 年第三季度,公司无拟增加门店情况。 三、2025 年前三季度主要经营数据: (一)主营业务分行业情况 1 单位:万元 币种:人民币 分行业 营业收入 营业成本 毛利率 (%) 营业收入 比上年同 期增减(%) 营业成本比 上年同期增 减(%) 毛利率比 上年同期 增减(%) 专业市场管理 31,883.24 7,288.51 77.14 0.12 1.69 下降 0.35 个百分点 商贸百货零售 9,634.62 4,856.26 49.60 -11.15 -6.74 下降 2.38 个百分点 商业管理 3,867.11 3,122.75 19.25 16.30 4.76 提高 8.89 个百分点 新零售业务 635.71 160.84 74.70 -70.78 -89.60 提高 45.78 个百分点 其他业务 1,707.00 827.77 51.51 -50.25 708.69 下降 45.5 ...
丽尚国潮:各区域主业均显示出发展韧性
Zheng Quan Ri Bao· 2025-08-27 16:13
Core Viewpoint - Lishang Guochao reported a mixed performance for the first half of 2025, with a decline in revenue but an increase in net profit, indicating resilience in its core business despite challenges in the retail environment [2][4]. Financial Performance - The company achieved operating revenue of 323.40 million yuan, a year-on-year decrease of 9.07% [2]. - The net profit attributable to shareholders was 79.73 million yuan, reflecting a year-on-year increase of 9.46% [2]. - Cash flow from operating activities showed significant improvement due to the recovery of receivables from the previous year [2]. Business Segments - The apparel wholesale markets in Hangzhou and Nanjing contributed significantly, generating revenue of 221 million yuan, a slight increase of 0.32% [2]. - The retail business centered around the Lanzhou Eurasia Department Store reported revenue of 64.15 million yuan, a decrease of 0.42% [2]. - The commercial management business, led by the Lanzhou Eurasia International Building, achieved revenue of 22.38 million yuan, an increase of 7.83% [2]. Strategic Focus - The company plans to focus on new development opportunities and external growth, although there are currently no specific acquisition targets [3]. - Lishang Guochao emphasizes its differentiated advantages, including proprietary properties in key commercial areas and digital management experience [3]. - The company is pursuing smart upgrades and innovation across its three main segments: professional markets, retail, and new retail [3]. Operational Adjustments - The company has adjusted its business structure to reduce asset impairment losses and has actively negotiated with banks to lower financial costs [4]. - The new retail business, which includes operations and services, will no longer be consolidated into the company's financial statements [4]. - Future resource investments will focus on digital platform construction, business model transformation, and team development [5].
九安医疗:新零售业务是公司主营业务的一小部分
Zheng Quan Ri Bao Wang· 2025-08-06 13:10
Core Viewpoint - The new retail business of Jiuan Medical is a small part of the company's main operations, contributing approximately 2.4% to the total revenue in 2024, which is estimated to be around 62.95 million yuan [1] Group 1 - The new retail business is relatively independent, involving decision-making by its own department [1] - The business primarily includes partnerships with Xiaomi specialty stores, Xiaomi integrated vehicle-home stores, and Xiaopeng Motors stores [1]
大连友谊(000679) - 2024年度业绩说明会投资者活动记录表
2025-05-16 09:08
Group 1: Business Performance - In 2024, the company achieved an operating income of 37,224.69 million yuan, representing a year-on-year increase of 127.90% [3] - The net profit attributable to shareholders was a loss of 7,763.99 million yuan, with a year-on-year increase in loss of 108.89% [3] Group 2: Cross-Border E-commerce - The retail income from bonded goods in 2024 was 10,462.46 million yuan, accounting for 28.11% of the total annual operating income [1] Group 3: Future Growth Strategies - The company plans to enhance revenue and profitability through: - Retail sector: Maintaining stable operations in offline department stores while seizing opportunities in new retail [4] - Online new retail: Deepening the new retail layout and optimizing the product cooperation system [4] - Real estate: Focusing on the transformation of the Dalian Jinshigu project [4]
九安医疗收盘上涨2.71%,滚动市盈率10.82倍,总市值182.63亿元
Sou Hu Cai Jing· 2025-05-13 04:28
Company Overview - Jiuan Medical closed at 38.6 yuan, up 2.71%, with a rolling PE ratio of 10.82 times and a total market value of 18.263 billion yuan [1] - The company ranks 32nd in the medical device industry, which has an average PE ratio of 49.84 times and a median of 36.59 times [1] - As of the first quarter of 2025, 36 institutions hold shares in Jiuan Medical, including 32 funds, 3 other entities, and 1 social security fund, with a total holding of 174.5256 million shares valued at 7.337 billion yuan [1] Financial Performance - In the first quarter of 2025, Jiuan Medical reported revenue of 507 million yuan, a year-on-year decrease of 33.49% [1] - The net profit for the same period was 266 million yuan, reflecting a year-on-year increase of 7.62% [1] - The sales gross margin stood at 70.46% [1] Industry Context - The medical device industry has a significant average PE ratio of 49.84 times, indicating a high valuation compared to Jiuan Medical's PE ratio [2] - The industry median PE ratio is 36.59 times, further highlighting Jiuan Medical's relatively lower valuation [2]
丽尚国潮(600738) - 丽尚国潮2025年第一季度主要经营数据公告
2025-04-29 14:17
一、2025 年第一季度,公司零售百货门店无关闭情况。 二、2025 年第一季度,公司无拟增加门店情况。 三、2025 年第一季度主要经营数据: 证券代码:600738 证券简称:丽尚国潮 公告编号:2025-025 兰州丽尚国潮实业集团股份有限公司 2025 第一季度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 兰州丽尚国潮实业集团股份有限公司(以下简称"公司")根据《上海证券交 易所上市公司自律监管指引第 3 号——行业信息披露》《关于做好主板上市公司 2025 年第一季度报告披露工作的重要提醒》要求,现将公司 2025 年第一季度主 要经营数据披露如下: 本公告之经营数据未经审计,公司董事会提醒投资者审慎使用该等数据。 (一)主营业务分行业情况 特此公告。 单位:万元 币种:人民币 兰州丽尚国潮实业集团股份有限公司董事会 | 分行业 | 营业收入 | 营业成本 | 毛利率 | 营业收入 比上年同 | 营业成本 比上年同 | 毛利率比 上年同期 | | --- | --- | --- | --- | - ...
丽尚国潮(600738):于变局中坚守,核心业务筑牢护城河
Xin Lang Cai Jing· 2025-04-29 12:52
Core Viewpoint - The government is promoting 2024 as the "Year of Consumption" to stimulate consumer potential and enhance service consumption quality, while Lishang Guochao (600738) is adapting its strategies to navigate the complex market environment and explore new business values and directions [1] Financial Performance - In 2024, Lishang Guochao achieved a revenue of 666.02 million yuan and a net profit attributable to shareholders of 72.55 million yuan, with basic earnings per share of 0.10 yuan, demonstrating business stability amid market fluctuations [1] - The first quarter of 2025 showed continued steady performance with a revenue of 177.43 million yuan and a net profit of 58.85 million yuan, with basic earnings per share of 0.08 yuan [1] Business Segments - The professional market management business, a core segment, showed resilience with a revenue of 419.23 million yuan and a gross margin of 76.10%, supported by high occupancy rates of 96.5% in Hangzhou and 95.6% in Nanjing [2] - In the retail sector, the Lanzhou Euro-Asian Shopping Center generated a revenue of 122.81 million yuan in 2024, leveraging digital strategies and local culture to enhance consumer engagement [3] - The new retail business segment reported a revenue of 26.39 million yuan in 2024, indicating strong growth potential through improved supply chain systems and digital investments [3] Policy Environment - Recent government initiatives, including the "Buy in China" campaign and the "Special Action Plan to Boost Consumption," aim to enhance domestic demand and stabilize the economy, creating opportunities for the consumption sector [4] - Analysts suggest that with external demand under pressure, expanding domestic demand will be crucial, and the consumption sector is expected to benefit from supportive fiscal policies and a rebound in consumer confidence [4] Future Outlook - Lishang Guochao is positioned to deepen its operations in commercial asset management and expand its market share, making it an attractive investment opportunity for those seeking stable returns [5]